Anti-Recombinant-SARS-CoV-2 Nucleocapsid protein antibody [22F9], Unconjugated, Human, Monoclonal
Catalog Number:
NBS-ASJ-BYQUQR-100
| Article Name: |
Anti-Recombinant-SARS-CoV-2 Nucleocapsid protein antibody [22F9], Unconjugated, Human, Monoclonal |
| Biozol Catalog Number: |
NBS-ASJ-BYQUQR-100 |
| Supplier Catalog Number: |
ASJ-BYQUQR-100 |
| Alternative Catalog Number: |
NBS-ASJ-BYQUQR-100 |
| Manufacturer: |
Nordic BioSite |
| Host: |
Human |
| Category: |
Antikörper |
| Application: |
ELISA, WB |
| Species Reactivity: |
Virus |
| Immunogen: |
Recombinant SARS-CoV-2 Nucleocapsid protein produced by CHO-based proprietary suspension cell line. Nucleocapsid protein SARS-CoV-2 |
| Conjugation: |
Unconjugated |
| Alternative Names: |
COVID19, COV2, SARS-COV, CORONA, COVID, COVID-19, SARS-COV-2, COV-2, NCOV |
| Clonality: |
Monoclonal |
| Clone Designation: |
[22F9] |
| Isotype: |
IgG1 l |
| Buffer: |
PBS pH 7.4 |
| Source: |
human |
| Purity: |
Protein A Purified |
| Target: |
Recombinant-SARS-CoV-2 Nucleocapsid protein |
| Antibody Type: |
Primary Antibody |
| Application Notes: |
ELISA 0.08-0.16 µg/ml |
